Alexis Anvekar MD ABIHM
CogSpan at Living Method is built for women navigating perimenopause and menopause, when hormonal shifts can cloud focus, memory, and mental clarity. Our evidence-informed program tackles brain fog at its root while addressing modifiable Alzheimer's risk factors—because midlife is a critical window for protecting long-term cognitive health. Through personalized assessment, targeted lifestyle strategies, and ongoing support, we help you sharpen your mind, safeguard your brain, and feel like yourself again.
The CogSpan-Perimenopause:
-perimenopause causes a 20% decline in brain glucose metabolism that may increase risk of Alzheimers.
Your brain fog may not be just in your head; it may be in the Silent Gap of Dementia.
Every woman going through menopause is told the same thing: the brain fog is hormonal, it's temporary, it'll pass as you suffer through it. What she's rarely told is that for many women, it's also the brain's first signal from The Silent Gap of Dementia, the 10-to-25-year window of silent neurological damage; a window that may be open right now, but won't stay that way.
​​
Is it menopause? Or are you in the most important neurological window of your life?
​
Your hot flashes, night sweats, brain fog and mood symptoms may be biomarkers of changes in the brain.
Is your brain sending SOS signals?
​
We are listening.
​
​
The Problem
What you call "brain fog,"
we call SOS signals.
​The brain is loaded with estrogen receptors — concentrated in the hippocampus, the region responsible for memory and learning. When estrogen declines during the menopausal transition, the brain doesn't just feel the loss. It undergoes measurable structural changes: reductions in gray matter volume in the frontal cortex and hippocampus, slowed cerebral metabolism, disrupted neurotransmitter signaling, and the beginnings of neuroinflammation.
​
Moreover, your brain may already be in the midst of putting out inflammatory fires from many other factors that may be causing brain aging and the reduction in estrogen might just be the last thing your brain is needing right now.
Over 60% of women experience cognitive symptoms during perimenopause or menopause. Most of them never get a clinical explanation. Almost none of them get a protocol designed to actually address what is happening neurologically. And tragically, most are told that all we need is hormone replacement therapy and if that doesn't work, there is nothing more to be done.​​​ We disagree.
The Solution:
Detect and Treat the Silent Gap
The most important window in your neurological life
Alzheimer's disease is typically diagnosed in the mid-to-late seventies. But the pathological changes, such as amyloid accumulation, synaptic loss, and metabolic dysfunction, begin 10 to 25 years earlier.
​
That means the seeds are planted in your fifties. Sometimes you're in your late forties. We call this The Silent Gap: the decade or two between the first detectable, modifiable drivers of brain aging and the diagnosis that arrives too late to reverse.
​
Additionally, if you live in the greater Los Angeles area, your brain fog may have an additional layer.​ The Eaton Canyon and Palisade fires of January 2025 released a significant burden of particulate matter, heavy metals, volatile organic compounds, and neurotoxic combustion byproducts into the air across Pasadena and the surrounding communities.
​
Environmental neurotoxin exposure is a documented, modifiable driver of brain aging — and for women already navigating the cognitive vulnerabilities of the menopausal transition, this exposure can compound symptoms significantly.
​
If you've noticed your perimenopause symptoms worsening since the fires — or if you've developed new symptoms but your hormone labs are reported to be "normal," you may especially benefit from environmental testing.
THE COGSPAN IMMERSIVE--MENOPAUSE FOCUS SYSTEM
​
This is not a hormone program with a cognitive twist. It is the most comprehensive multi-modal brain optimization protocol available for women in perimenopause and menopause — built to identify every modifiable driver of your brain fog and address it directly, simultaneously, and strategically.
​
Six layers. One protocol. Designed for the window that may already be closing.
​
LAYER 01 — CogSpan 6-month Immersive System
Before we treat anything, we measure everything. A whole body and brain audit to find any factors that may be causing brain inflammation. In addition to your first 2 hour appointment for labs, lifestyle questionairre, physical testing, we administer BrainCheck — a validated digital cognitive assessment that can be administered virtually — we establish your personal baseline across processing speed, working memory, attention, executive function, anxiety, depression and childhood trauma screening. This is a full battery of tests that assessse your real neurological benchmark that we track over time, so every intervention is measured against your own objective standard. We include many biomarkers such as Environmental Toxins, Organic Acids, etc.
​
​​​
​
LAYER 02 — Precision Hormone Optimization and Prescription management and Menopause Coaching
We go far beyond a standard hormone panel. Comprehensive testing of sex hormones, cortisol, and thyroid gives us the full picture of your hormonal environment. Where appropriate, we integrate hormone therapy guided by the critical window hypothesis — the emerging evidence that hormone therapy initiated close to the onset of menopause offers the greatest neuroprotective benefit. If you are already receiving hormone therapy elsewhere, we work alongside your existing care.
​​​​​​
LAYER 03 — Targeted Supplement Recommendation
Carefully selected hormone-supportive micronutrients and botanicals support estrogen metabolism, neuronal resilience, and mitochondrial function. We pay particular attention to sleep architecture — because without restorative deep sleep, the brain's glymphatic waste-clearance system fails nightly, and cognitive toxins accumulate. Sleep is not a lifestyle factor. It is a neurological intervention.
​
LAYER 04 — Neuropeptide Therapy: Semax & Selank
The most innovative layer of the Stack — and the one most unlike anything else available in this space.
Peptides are short chains of amino acids that act as precise signaling molecules in the brain, working with its native architecture rather than overriding it.
Semax is a synthetic derivative of ACTH developed at the Institute of Molecular Genetics of the Russian Academy of Sciences and has been in clinical use in Russia for over three decades — prescribed for stroke recovery, traumatic brain injury, and cognitive impairment. Its most significant mechanism is for brain health: it powerfully elevates BDNF (brain-derived neurotrophic factor), the protein most responsible for neuroplasticity, new synaptic connections, and learning. In a small controlled human trial, a single intranasal dose produced 71% accuracy on a memory test versus 41% in controls.
Selank is a synthetic analog of tuftsin, a naturally occurring human immunopeptide, approved in Russia for generalized anxiety disorder in 2009. It works through GABAergic and serotonergic pathways to reduce anxiety, regulate the stress response, and support cognitive clarity — without sedation, without dependence, and without the cognitive blunting of benzodiazepines.
​
​​​​​These peptides are not FDA-approved and are used as an investigational component of a fully supervised clinical protocol, with full informed consent and ongoing monitoring. They are obtained through a licensed 503A or 503B compounding pharmacy when possible and supplies avaailable, and are always prescribed on a patient-specific basis. Their absence from the US market reflects pharmaceutical economics — they are natural peptides that cannot be patented. Russian clinical experience spans three decades, though large-scale randomized controlled trials meeting current FDA standards have not been conducted.